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Hypertonicity stimulates PGE2 signaling in the renal
medulla by promoting EP3 and EP4 receptor
expression
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Hypertonicity in the renal medulla stimulates local
cyclooxygenase 2 expression, leading to abundant
PGE2 production. Here we found that mRNA expression by
the PGE2-activated G-protein-coupled receptors, EP3 and EP4
in the renal medulla was decreased by furosemide treatment,
a procedure that reduces medullary hypertonicity. When
HepG2 cells were cultured in hypertonic conditions by
addition of salt or sorbitol, EP3 expression was induced.
A specific EP3 agonist inhibited cAMP production, indicating
receptor functionality, and this led to a substantial increase in
cell survival in hypertonic media. Survival was independent
of the SLC5A3 inositol transporter and aldose reductase
expression, suggesting that EP3 promoted cell survival under
hypertonic conditions independent of cellular organic
osmolyte accumulation. Reduced cAMP production did not
contribute to increased survival. EP4 expression was
stimulated by hypertonicity in MDCK and HepG2 cells, which
was associated with increased cAMP production in response
to an EP4 agonist. Our study shows that local hypertonicity
promotes PGE2 signaling in the renal medulla by stimulating
cognate receptor and cyclooxygenase 2 expression that likely
regulates local hemodynamics and tubular transport.
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Operation of the urinary concentrating mechanism produces
hyperosmolality in the interstitium of the renal medulla due
to the accumulation of salt and urea. Although the interstitial
osmolality fluctuates depending on physiological and patho-
physiological conditions, it stays hyperosmotic even when
hypoosmotic urine is produced.1 Thus, the cells in the renal
medulla are continuously bathed in hyperosmolality under
most conditions.
Salt and urea exert fundamentally different effects on cells.
Hyperosmotic salt is hypertonic, that is, causes net efflux of
water across the plasma membrane raising the cellular ionic
strength. Exposure to hypertonicity results in double
stranded DNA breaks2 and, depending on the degree of
hypertonicity, cell cycle arrest or cell death.3 Cells adapt to
the hypertonic insults by activating several pathways. (1)
Repair of the DNA breaks takes place over the course of
several hours2 as much of the DNA damage signaling remains
active in hypertonic conditions.4 (2) Normal cellular ionic
strength is restored as the ions are osmotically replaced by the
massive accumulation of organic osmolytes. Stimulation of
transcription by the transcription factor TonEBP is a key
event in the accumulation of organic osmolytes. This is
because expression of the active plasma membrane transpor-
ters and biosynthetic enzymes involved in the cellular
accumulation of organic osmolytes is transcriptionally
stimulated by TonEBP.5 (3) Cyclooxygenase 2 (COX-2) is
constitutively expressed in the renal medulla because of
transcriptional stimulation by local hypertonicity in a
manner dependent on nuclear factor-kB6 but independent
of TonEBP.7 The high COX-2 activity leads to abundant
production of prostaglandin E2 (PGE2) which promotes cell
survival against hypertonic stress in a manner independent of
organic osmolyte accumulation.8
Urea is highly permeable to the plasma membrane and,
therefore, a hyperosmotic fluid made by addition of urea is
not hypertonic. Nonetheless, over 300 mM urea, which is
routinely found in the inner medullae of mammal kidneys,
causes oxidative DNA damages9 and cell death.3 Heat-shock
protein 70 (HSP70) which is highly expressed in the renal
medulla contributes to the protection from the deleterious
effects of urea.10 Both TonEBP and COX-2 are involved in the
high expression of HSP70. TonEBP binds directly to the
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promoter of the HSP70 gene and stimulates its transcription.7
One of the prostaglandin metabolites found in the renal
medulla, D12-PGJ2, directly stimulates heat-shock factor 1
and as a result the transcription of HSP70.11 It is interesting
to note that cellular responses to hypertonicity, namely
stimulation of TonEBP and expression of COX-2, are critical
in protecting the renal medulla not only from the deleterious
effects of hypertonicity itself, but also from the harmful
effects of urea.
In this study we found that expression of the G-protein-
coupled receptors for PGE2 in the renal medulla was
transcriptionally stimulated in response to ambient hyperto-
nicity. The receptors mediated the pro-survival signal and are
known to modulate local hemodynamics and tubular
transport processes. Thus, we have found yet another cellular
response to hypertonicity which is critical to the function of
the renal medulla.
RESULTS
Reduced expression of EP3 and EP4 mRNA in the renal
medulla in response to furosemide treatment
We were interested in those genes whose expression in the
renal medulla was promoted by the local hyperosmolality. To
find these genes, we decided to look for downregulated genes
in response to washout of the hyperosmolality in the renal
medulla using the diurectic furosemide as described in
‘Materials and Methods’. Functional genomic screening of
RNA samples revealed many genes downregulated in
response to furosemide treatment including the PGE2
receptors EP3 and EP4 (data not shown). To confirm the
downregulation of EP3 and EP4 mRNA, we performed
quantitative reverse transcriptase (RT)-PCR on a separate set
of RNA samples. As shown in Figure 1, the abundance of EP3
mRNA decreased more than 60% in the outer medulla and
inner medulla in response to furosemide. Because of large
variations in vehicle groups and small sample numbers
(n¼ 4), statistical significance was reached only in the outer
medulla after 1 day of treatment and in the inner medulla
after 5 days. Significant reduction in the abundance of EP4
mRNA was also seen in the inner medulla after 5 days of
treatment. These results confirm that expression of the EP3
and EP4 mRNA in the renal medulla is reduced by
furosemide treatment raising the possibility that the expres-
sion of EP3 and EP4 is promoted by hyperosmolality.
Induction of EP3 and EP4 by hypertonicity
We examined kidney-derived cell lines—Madin–Darby canine
kidney (MDCK) and mIMCD3 cells—for expression of EP3
and EP4. RT–PCR analyses revealed that MDCK cells
expressed EP2 and EP4 (Figure 2a), and mIMCD3 cells
expressed EP1 and EP4 (not shown). In MDCK cells, the
amount of the EP4 RT–PCR product increased in response to
hypertonicity in correlation with increase EP4 protein
expression (Figure 2b) demonstrating the induction of EP4
by hypertonicity. The amount of the EP2 RT–PCR product
also increased in the hypertonic cells. However, we could not
demonstrate increased EP2 expression because immunoblot
analysis did not work. We screened a number of other cell
lines to find cells that expressed both EP3 and EP4, but not
EP1 and EP2. The lack of EP1 and EP2 would allow
examination of the physiological role of EP3 or EP4 without
the complications stemming from EP1 and EP2. We found
that HepG2 cells satisfied these criteria (Figure 2a). Although
HepG2 cells are not derived from the kidney, they provide an
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Figure 1 | Effects of furosemide on renal expression of EP3
and EP4 mRNA. Rats were administered vehicle or furosemide
(40 mg/day) for 1 day (open bars) or 5 days (solid bars). mRNA for
EP3 and EP4, and 18S rRNA were measured from outer medulla
(OM) and inner medulla (IM) of the kidney using quantitative RT-
PCR. The abundance of EP3 or EP4 mRNA was corrected for RNA
loading using the abundance of 18S rRNA. Abundance of mRNA in
furosmide-treated animals relative to vehicle treated animals is
shown. Meanþ s.e.m., n¼ 4. *Po0.05, #Po0.01 compared to
vehicle.
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Figure 2 | Effects hypertonicity on expression of EP3 and EP4.
(a) Confluent MDCK and HepG2 cells were cultured for 24 h in
isotonic (I) or hypertonic medium (H, made by addition of 100 mM
NaCl). RT–PCR was performed to detect mRNA for EP1, EP2, EP3,
EP4, or GAPDH (glyceraldehyde 3-phosphate dehydrogenase). The
amplified bands were confirmed by sequencing. A representative
of three independent experiments is shown. (b) Confluent MDCK
cells cultured as in a for 24–72 h were immunoblotted for EP4
and HSC70.
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ideal system to investigate the regulation and function of EP3
and EP4 at the cellular level. This information would provide
useful insight into their function in the kidney.
Using HepG2 cells, we asked whether expression of EP3
and EP4 was promoted by hyperosmolality. As salt and urea
are the major solutes in the hyperosmotic interstitial fluid of
the renal medulla, we tested two different hyperosmotic
culture media—one made by addition of NaCl, and another
by addition of urea. In normal isoosmotic conditions, mRNA
for the PGE2 receptor EP1, EP2, or EP3 was not detected by
RT–PCR in HepG2 cells, whereas EP4 mRNA was detected at
a very low level (Figure 2). Essentially the same results were
obtained when the cells were cultured in hyperosmotic
medium made by addition of urea (not shown; see more
below). On the other hand, when the cells were cultured in
hyperosmotic medium made by addition of NaCl, that is,
hypertonic medium, EP3 and EP4 mRNA were clearly and
consistently detected indicating that their expression was
enhanced by hypertonicity.
The expression of EP3 and EP4 and its regulation by
hyperosmolality were further characterized. First, the mRNA
was quantified using RNase protection assay (RPA). As
shown in Figure 3a, expression of the EP3 mRNA was very
low in isotonic conditions. In response to hypertonicity, the
abundance of EP3 mRNA increased significantly after 16 h,
reaching a peak of eightfold increase at 24 h. Urea was
ineffective as a hyperosmotic solute in enhancing the mRNA
abundance, whereas sorbitol was as effective as NaCl
confirming that hypertonicity rather than hyperosmolality
per se was the signal for the expression of EP3 mRNA (Figure
3b). Essentially the same results were observed for the
expression of EP4 mRNA except that the time course of
induction by hypertonicity was faster, reaching a peak of
fivefold increase at 16 h, and then, declining toward the basal
level (Figure 4a and b). The induction of EP3 and EP4 mRNA
was observed in the presence or absence of serum (data not
shown) excluding a role of factors in the serum.
Next, we examined expression of the EP3 and EP4
proteins. Immunoblot analysis revealed that EP3 was induced
by hypertonicity, but not by hyperosmolality made by
addition of urea (Figure 3b). EP3 expression decreased 48 h
after the switch to hypertonicity compared to 24 h but stayed
higher than isotonic control (not shown) in line with the
decline in mRNA abundance. EP3 is coupled to the
inhibitory G protein Gi which inhibits cyclic AMP (cAMP)
production.12 To demonstrate the functionality of EP3, we
examined the effect of EP3 agonist sulprostone on forskolin-
stimulated cAMP production (Figure 3c). In HepG2 cells
cultured in isotonic conditions or those cells cultured in
hyperosmotic medium made by addition of urea, sulprostone
did not affect the forskolin-stimulated cAMP production. On
the other hand, those cells that had been cultured in
hypertonic medium displayed a reduction in the forskolin-
stimulated cAMP production in response to sulprostone
treatment indicating that these cells did express functional
EP3 in agreement with the immunoblot data. Thus,
functional EP3 was induced in response to hypertonicity in
correlation with its mRNA expression.
Like EP3, EP4 was induced by hypertonicity in HepG2
cells based on immunoblot analysis except that low level of
EP4 was also detected in cells cultured in isotonic medium or
hyperosmotic medium made by addition of urea (Figure 4b).
Like EP3, EP4 expression decreased 48 h after the switch to
hypertonicity compared to 24 h but stayed higher than
isotonic control (not shown) in line with the decline in
mRNA abundance. The same pattern of EP4 induction was
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Figure 3 | Induction of EP3 in response to hypertonicity. (a)
Confluent HepG2 cells were switched to hypertonic medium
containing an additional 100 mM NaCl for up to 48 h, as indicated.
RPA was performed to detect mRNA for EP3 and b-actin. The
abundance of EP3 mRNA was corrected for RNA loading using the
abundance of b-actin mRNA and is presented as mean±s.e.m.
(n¼ 3). *Po0.05, #Po0.01 compared to 0 h. (b) Cells were
cultured for 24 h in isotonic medium (ISO) or hyperosmotic
medium made by addition of 100 mM NaCl (NaCl), 200 mM sorbitol
(Sorbitol), or 200 mM urea (Urea) as indicated. mRNA for EP3 and
b-actin were detected by RPA. EP3 and HSC70 proteins were
detected by immunoblot analyses. A representative set of three
independent experiments is shown. NS, nonspecific band. (c) Cells
cultured as in b were serum-starved for 2 h, and then treated with
vehicle or 1 mM sulprostone for 45 min. Those cells treated with
sulprostone and half of the cells in vehicle were further treated
with 1 mM forskolin (FSK) in the last 15 min, as indicated. Cellular
content of cAMP was measured and expressed relative to ISO
vehicle. Meanþ s.e.m. (n¼ 3). *Po0.05, #Po0.01.
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also observed in MDCK cells (Figure 2). As EP4 was coupled
to the stimulatory G protein Gs
12 we examined the effects of
EP4 agonist PGE1-OH on cellular content of cAMP (Figure
4c). We noticed that cellular content of cAMP was
consistently lower in those cells cultured in hypertonicity
(Figures 3c and 4c). In these cells, however, but not in those
cells in isotonicity or hyperosmolality with additional urea,
cAMP production was stimulated by 1mM PGE1-OH
demonstrating the expression of functional EP4. Taken
together, the data in Figures 3 and 4 demonstrate that
expression of EP3 and EP4 is induced by ambient
hypertonicity.
EP3 promotes of cell survival from hypertonic stress
PGE2 promotes the survival of MDCK cells under hyperto-
nicity essentially in a manner independent of cellular
accumulation of organic osmolytes.8 We tested whether
EP3 or EP4 mediated the pro-survival signal of PGE2. In
control serum-free conditions, 25–35% of cells survived after
24 h in hypertonicity (Figure 5). Unlike the previous report,8
PGE2 did not affect the viability of HepG2 cells in hypertonic
conditions (not shown). Instead, we found that a stable
derivative 16,16-dimethyl PGE2 (DM-PGE2) promoted
survival of HepG2 cells in a dose-dependent manner (Figure
5a). Sulprostone also promoted cell survival at 1 mM (Figure
5b). On the other hand, PGE1-OH did not increase cell
survival except at high concentrations (50 mM). As EP4 was
activated at much lower concentration of PGE1-OH, that is,
at 1mM (Figure 4c), the protective effects at high dose were
likely due to activation of EP3. In isotonic conditions, DM-
PGE2, sulprostone, or PGE1-OH did not affect the cell
viability (data not shown). Taken together, the results
demonstrate that the EP3 mediates the pro-survival signal
of PGE2 in hypertonic conditions.
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Figure 4 | Induction of EP4 in response to hypertonicity.
(a) Cells were cultured as in Figure 3a, and the abundance of EP4
mRNA is shown as mean±s.e.m. (n¼ 3). #Po0.01 compared to
0 h. (b) Cells were treated for 16 h as in Figure 3b. mRNA for EP4
and b-actin were detected by RPA, and EP4 and HSC70 proteins
were defected by immunoblot analyses. A representative set of
three independent experiments is shown. (c) Cells were cultured
as in Figure 3c. After serum starvation for 2 h, the cells were
treated for 30 min with 0.5 mM IBMX alone or in combination with
1 mM PGE1-OH. IBMX alone did not affect cAMP content in isotonic
or hypertonic conditions (not shown). Cellular content of cAMP
was measured and expressed relative ISO vehicle. Meanþ s.e.m.
(n¼ 3). *Po0.05.
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Figure 5 | Effects of EP3 and EP4 agonists on cell survival in
hypertonicity. HepG2 cells were cultured for 24 in serum-free
hypertonic medium containing an additional 100 mM NaCl. (a)
16,16-Dimethyl PGE2 (DM-PGE2), (b) sulprostone, or (c) PGE1-OH
was added to the medium at concentrations indicated. Cells were
collected after trypsin digestion and viable cells were counted
using Trypan blue exclusion. Percentage of viable cells relative to
the number of cells at the start of treatment is shown.
Mean±s.e.m. (n¼ 3). *Po0.05, #Po0.01 compared to vehicle.
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The action of EP3 is known to be mediated by
phospholipase C, Rho, and other pathways, in addition to
the inhibition of adenylate cyclase.12 Although we chose to
examine cAMP in order to demonstrate the functionality of
EP3 in Figure 3, we do not know whether a reduction in
cellular cAMP content is required for the pro-survival action
of EP3. We found that the elevated cAMP in response to 1mM
forskolin (Figure 3c) was not associated with changes in cell
survival (28±1.8 (forskolin) vs 24±1.3% viability (vehicle),
n¼ 3, P40.1). These data do not support the view that the
pro-survival action of EP3 was mediated by the decreased
cAMP content.
We examined the role of TonEBP in the pro-survival
effects of EP3. We found that expression of TonEBP was
stimulated by DM-PGE2 but not by sulprostone (Figure 6a).
The increased expression of TonEBP resulted in only a small
increase in the expression of AR and SMIT mRNA suggesting
that the activity of TonEBP was not greatly affected. These
data demonstrate that cellular accumulation of organic
osmolytes has minimal role in the protective action of
PGE2 as reported previously.
8
DISCUSSION
Hypertonicity of the interstitium is a defining feature of the
renal medulla. Our data shown here provide two lines of
evidence that expression of the PGE2 receptors EP3 and EP4
in the renal medulla is driven by the local hypertonicity. First,
expression of the receptors’ mRNA decreased when the
medullary hypertonicity was reduced using furosemide.
Second, expression of the receptors in MDCK and HepG2
cells was induced by ambient hypertonicity in association
with increased mRNA abundance. The induced receptors
conferred agonist-specific signaling which was not observed
in cells under isotonicity or hyperosmolality made by
addition of urea. Thus, hypertonicity promotes the PGE2
signaling in the renal medulla by promoting expression of
cognate receptors.
Like other prostaglandins, PGE2 provides a local autocrine
or paracrine signaling that is complex and context dependent.
The complexity is due, in part, to the four different types of
receptors (EP1, EP2, EP3, and EP4), each of which displays
unique expression pattern within the kidney. EP3 is expressed
main in the thick ascending limb of the Henle’s loop, and the
collecting ducts in the cortex and medulla.13,14 In these tubule
segments, EP3 counteracts the vasopressin action by reducing
cAMP production.15,16 As expected, activation of EP3 leads to
acute inhibition of sodium-potassium-chloride transporter 2
(NKCC2) and aquaporin 2 (AQP2) because the apical
trafficking of these proteins is dependent on cAMP.17,18 In
addition, expression of NKCC2 and AQP2 is also inhibited by
EP3 or stimulated by inhibitors of cyclooxygenase.19,20 This
pathway contributes the side effects of cyclooxygenase
inhibitors in the sodium retention and edema,12 and the
downregulation of NKCC2 and AQP2 in urethral obstruc-
tion.21 In addition, PGE2 protects cells from the hypertonicity
in early phase after exposure to hypertonicity before the
cellular accumulation of organic osmolytes and the normal-
ization of cellular ionic strength.8 Our data in Figure 5 show
that this is mediated by EP3. On the basis of these findings in
this study, we propose a model in which local hypertonicity in
the renal medulla is a signal to modulate the action of
vasopressin (Figure 7). This model shows that the hyperto-
nicity-induced EP3 modulates excessive reabsorption of salt
and water, and also protects the resident cells in the renal
medulla from the increasing hypertonicity.
Although EP4 expression in the kidney is prominent in
the glomerulus and the afferent arteriole, EP4 is also detected
in the medulla22—collecting duct, thick ascending limb, and
vasa recta—consistent with the data in Figure 1. A recent
study found that EP4 and COX-2 coexpressed in blood
vessels of human kidneys including the vasa recta and
medullary capillaries suggesting a major role of EP4 in the
renal circulation in human.23 EP4 has been shown to be
involved in blood pressure regulation in two distinct ways.
EP4 along with EP2 stimulates renin release from the
juxtaglomerular granular cells.24 This pathway is involved
in the hypertension induced by renal arterial stenosis. In
addition, EP4 and EP2 are believed to mediate vasodilation in
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Figure 6 | Effects of EP3 and EP4 agonists on expression of
TonEBP and its target genes. HepG2 cells were cultured for 24 h
in serum-free hypertonic medium containing vehicle (DMSO),
10mM DM-PGE2, 1 mM sulprostone, or 50mM PGE1-OH, as indicated.
(a) TonEBP and HSC70 were detected by immunoblot analyses.
The TonEBP abundance was corrected for protein loading using
the abundance of HSC70 and presented as meanþ s.e.m. (n¼ 3).
#Po0.01 compared to vehicle. (b, c) mRNA for AR, SMIT, and b-
actin were measured by RPA. Abundance of AR and SMIT mRNA
was corrected for RNA loading using the abundance of b-actin
mRNA and expressed as meanþ s.e.m. (n¼ 3). *Po0.05, #Po0.01
compared to vehicle.
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the afferent arteriole25 and vasa recta.26 The vasodilation of
the vasa recta contributes to the pressure natriuresis by
increasing the interstitial pressure.27 Thus, EP4 modulates the
local physiology to prevent excessive renal response to
systemic signals in a manner analogous to EP3 as depicted
in the model (Figure 7). In support of this model, it was
shown recently that inhibition of NKCC2 decreased the
medullary blood flow in correlation with reduced medullary
tonicity in a manner sensitive to COX-2 inhibition.28
Taken together, the data presented here provide a new
layer of insight into the local modulation by PGE2 in the
renal medulla. The local hypertonicity promotes the PGE2
signaling via the production of PGE2 and the expression of its
cognate receptors. The PGE2 signaling in turn buffers the
renal response to incoming systemic signals and insults such
as vasopressin or vasoconstrictors to protect the kidney as
well as to prevent excessive and harmful responses.
MATERIALS AND METHODS
Animal experiments
With the approval from the University of Maryland Animal Use and
Care Committee, male Sprague–Dawley rats weighing 200 g (Harlan
Sprague–Dawley Inc., Indianapolis, IN, USA) were each implanted
with an ALZET osmotic pump (Model 2ML1; Durect Corporation,
Cupertino, CA, USA) that releases vehicle (50% dimethyl sulfoxide,
pH 8.0) or 40 mg/day of furosemide as described.29 After 1 day or 5
days, the animals were killed by pentobarbital overdose and RNA
was isolated from kidneys using Trizol reagent (Invitrogen, Carlsbad,
CA, USA).
Quantitative RT-PCR
RNA samples obtained from kidneys were treated with DNase I
and reverse transcribed using a commercial kit (SuperScript III
First-Strand Synthesis System; Invitrogen). PCR was performed in
iCycler (Bio-Rad, Hercules, CA, USA) using a commercial SYBR
green reaction mix (Bio-Rad) and the following primers: ccagct
tatggggatcatgt and aacggcgattaggaaggaat for rat EP3 (NCBI accession
D14869), ggtgcagagatccagatggt and attctgatggcctgcaaatc for rat EP4
(U94709), and gacaattattccccatgaacg and ggcctcactaaaccatccaa for
rat rRNA (X01117). The EP3 or EP4 mRNA level in each sample was
divided by that of rRNA to correct for RNA loading.
Cell culture
MDCK cells and HepG2 cells, a human hepatocellular liver
carcinoma-derived cell line, were maintained in Minimum Essential
Medium (Invitrogen) supplemented with 10% fetal bovine serum
(Gemini Bio-Products, Woodland, CA, USA), 0.1 mM nonessential
amino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen),
100 mg/ml streptomycin, and 100 U/ml penicillin (Invitrogen).
Where indicated, osmolality of the medium was increased by
addition of NaCl, sorbitol, or urea.
RT–PCR
RNA isolated from MDCK and HepG2 cells were reverse transcribed
as described above. PCR was performed on the cDNA for 30 cycles
using High Fidelity PCR Master Mix (Roche Molecular Biochem-
icals, Indianapolis, IN, USA). Primers used were: for dog EP1,
ggtcatccggagccatccgg and gccagcgccagcacgttggac (XM_848325); hu-
man EP1, tgcatggtcttcttcggcctgtg and caggccgatgaagcaccacgtgc
(NCBI locus NM_000955); dog EP2, gggtcggaggactgcgagtc and
caggtcccgagcaggtcggtg (AF075602); human EP2, tgactcccagtctgagg
actgcgagac and aaagcgaagtaggtgcacgcgcggctct (NM_000956); dog
EP3, cctcaaccactcctacacaggc and gccagccagccgatgcacagc
(NM_001002958); human EP3, caacgggactagctcttcgcataactgg and
cctggcttcactgaaccagatcttggat (NM_011196); dog EP4, cgtccgaacag
cccggtgacc and ggatgaaggtgctgtactcgcag (AF177934); human EP4,
gccgagatccagatggtcatcttac and agatgtcctttgactgtctgagca (NM_000958);
dog GAPDH, gcctggtcaccagggctgc and gttctcagccttgactgtgccg
(NM_001003142); human GAPDH, acccagaagactgtggatgg and
ttcagctcagggatgacctt (NM_002046). PCR products were cloned into
pCRII vector and sequenced for verification.
RNase protection assay
RPA was performed using a commercial kit (Ambion, Austin, TX,
USA). The RT–PCR clones for human EP3 and EP4 (see above) were
used to generate probes for EP3 and EP4 mRNA. Probes for human
SMIT (corresponding to nucleotides 1618–1967 of NM_006933) and
AR (corresponding to nucleotides 608–992 of NM_020299) were
generated by RT–PCR. Probe for the human b-actin mRNA was
obtained from Ambion. Radioactivity of protected bands was
quantified using a Phosphor Imager (Bio-Rad).
Immunoblot analyses
Cells were washed with phosphate-buffered saline or phosphate-
buffered saline containing additional NaCl or urea for cells treated
with hyperosmotic medium. Cells were collected by scrapping and
centrifugation. Boiling lysis buffer (1% SDS, 1 mM sodium
orthovanadate, and 10 mM Tris, pH 7.4) was added to the cell
pellet, and the mixture was passed through a 24-G needle to
homogenize. Protein concentration was determined with the BCA
Protein assay kit (Pierce Biotechnology Inc., Rockford, IL, USA).
Equal amounts of the cell lysates were separated on 10%
SDS–polyacrylamide gel. The gel was transferred onto a PVDF
membrane (Millipore, Billerica, MA, USA). For immunodetection,
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Figure 7 | Promotion of PGE2 signaling in the renal medulla by
local hypertonicity NKCC2-driven salt accumulation in the
medullary interstitium creates hypertonicity. PGE2 production
and expression of EP3 and EP4 are promoted by the hypertonicity.
Activated EP3 modulates salt and water absorption by inhibition
of cAMP production. EP3 also promotes cellular survival of the
stress of hypertonicity. EP4 enhances medullary blood flow by
dilating vasa recta. See text for other details.
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blots were incubated overnight in phosphate-buffered saline
containing 0.1% Tween-20 and 5% skim milk with the anti-EP3
(Cayman Chemical, Ann Arbor, MI, USA), anti-EP4 (Cayman
Chemical), or TonEBP antibody30 at a 1:1000 (EP3 and EP4) or
1:5000 (TonEBP) dilution. The blots were then incubated with a
secondary antibody conjugated to horseradish peroxidase (Cell
Signaling Technology Inc., Danvers, MA, USA) and visualized using
chemiluminescence reagents (Pierce Biotechnology Inc.). Each
membrane was reprobed with HSC70 antibody (Stressgen, Victoria,
BC, Canada) to assess protein loading.
cAMP assay
Confluent HepG2 cells in six-well plates were cultured in isotonic or
hyperosmotic medium for 24 h. After treatments with various
reagents as indicated in Figure 3 or 4, cellular content of cAMP was
measured using Correlate-EIA Direct cyclic AMP kit (Assay Designs,
Ann Arbor, MI, USA).
Assessment of cell survival
A total of 2 million HepG2 cells were seeded in each well of six-well
plates and cultured overnight in complete medium. After serum
starvation for 3 h, the cells were cultured for 24 h in serum-free
hypertonic media containing various inhibitors. Before and after the
treatment with the hypertonic media, adherent cells were collected
by digestion with trypsin and centrifugation. The trypsin solution
was not made hypertonic for those cells cultured in hypertonic
conditions. This might have led to an underestimation of cell
survival for these cells. Viable cells were counted in a hemocyt-
ometer using Trypan blue exclusion.
Statistical analysis
Data are expressed as mean±s.e.m. The significance between the
mean values was analyzed by Student’s t-test using Excel software
(Microsoft, Redmond, WA, USA).
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